EU Business News: BioGaia Acquires US Distributor, Spain's Rubió Enters VMS Market, Sidefarma Gets PE Backing
Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.
You may also be interested in...
Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.
UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.
France's medicines regulator ANSM has added 12 OTCs to its "free access" list of products available for self-selection by consumers in pharmacies.